PSYCHONEUROENDOCRINOLOGY is a leading journal published by PERGAMON-ELSEVIER SCIENCE LTD, dedicated to advancing the understanding of the interplay between psychological, neurological, and endocrine systems. Since its inception in 1975, the journal has emerged as a critical resource for researchers in fields such as biological psychiatry, endocrinology, and neuroscience, achieving prestigious quartile rankings including Q1 in Endocrine and Autonomic Systems and Q1 in Psychiatry and Mental Health as of 2023. With a strong focus on original research and comprehensive reviews, PSYCHONEUROENDOCRINOLOGY fosters an engaging platform for the exchange of innovative ideas, findings, and methodologies. Although not an open access journal, it provides broad access through institutional subscriptions, making it an invaluable asset for students, professionals, and researchers alike, keen to delve into the latest developments in this interdisciplinary field. With an impressive Scopus ranking and high percentiles across multiple categories, this journal stands at the forefront of scientific inquiry pertaining to the intricate relationships between mind and body, paving the way for novel therapeutic approaches and enhancing our understanding of mental health disorders.

TOXICOLOGY AND APPLIED PHARMACOLOGY, published by Academic Press, Inc. Elsevier Science, stands as a leading journal in the domains of toxicology and pharmacology, with its establishment dating back to 1959. With an impact factor reflecting its academic rigor and relevance, this journal is classified in the Q2 quartile for both pharmacology and toxicology categories, underscoring its significance in the scientific community. It ranks #34 out of 133 in Toxicology and #95 out of 313 in Pharmacology according to Scopus, placing it within the 74th and 69th percentiles, respectively. The journal aims to disseminate quality research that drives advancements in understanding the interactions of drugs and toxic substances within biological systems. Researchers and professionals are invited to contribute and engage with a broad spectrum of articles that cover mechanistic studies, risk assessment, and innovative therapeutic strategies. Although the journal does not offer open access, it continues to be a crucial resource for those who seek to navigate the complex interface of drugs and their toxicological implications.

COGNITIVE NEUROPSYCHOLOGY, published by ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD, is a premier academic journal that has established itself as a vital resource in the fields of cognitive neuroscience, neuropsychology, and psychology since its inception in 1984. With an esteemed impact factor that reflects its significance within the academic community, this journal is classified in the Q1 category for Arts and Humanities (miscellaneous) and Q2 in various other fields, including Cognitive Neuroscience and Developmental Psychology, based on the latest evaluation of 2023. COGNITIVE NEUROPSYCHOLOGY provides a platform for the dissemination of innovative research findings and theoretical advancements that deepen our understanding of cognitive processes and behavior in relation to neural systems. The journal also boasts a robust Scopus ranking, ensuring that articles published are of the highest caliber. Though it follows a traditional publishing model, the journal's commitment to rigorous peer review guarantees that it remains an authoritative voice for researchers, professionals, and students devoted to advancing knowledge in these critical areas of study.

Toxicology and Environmental Health Sciences is a peer-reviewed journal published by the Korean Society for Environmental Risk Assessment & Health Science, dedicated to advancing the fields of toxicology and environmental health. With an ISSN of 2005-9752 and E-ISSN 2233-7784, this journal serves as a vital platform for researchers, professionals, and students seeking to explore the intricate relationships between environmental risks and public health. Operating from South Korea, it has a converged years span from 2009 to 2024, and currently holds a respectable Q3 quartile ranking in both Health, Toxicology and Mutagenesis and Toxicology. This positions the journal within a critical space for those invested in understanding and mitigating environmental health challenges. Although not an open-access journal, it continues to foster high-impact research, contributing to a better understanding of toxicological sciences and environmental health dynamics. Engage with the latest findings and discussions that shape this evolving field through the insightful articles published herein, reinforcing its importance as a resource for scholars and practitioners alike.

Birth Defects Research is a premier open-access academic journal published by WILEY, dedicated to advancing the field of developmental biology and embryology, with an emphasis on understanding the mechanisms and factors influencing congenital anomalies. Since its establishment, the journal serves as a vital resource for researchers, professionals, and students alike, providing a platform for innovative research and insights in areas including pediatrics, toxicology, and health science. With an impact factor reflecting its commitment to quality, it is positioned in the Q2 and Q3 quartiles across several categories for 2023, demonstrating its relevance and influence within the scientific community. Researchers will find it particularly valuable for disseminating findings and encouraging interdisciplinary collaboration in combatting birth defects and improving child health outcomes. Accessible from the United Kingdom, the journal fosters the free exchange of information, reinforcing its goal to support the global health landscape through knowledge and innovation.

Welcome to the JOURNAL OF COGNITIVE NEUROSCIENCE, a premier publication in the field of cognitive neuroscience, published by the esteemed MIT PRESS. Since its inception in 1989, this journal has been at the forefront of advancing our understanding of the neural mechanisms underlying cognitive processes, boasting an impressive convergence period through 2024. With its Q1 ranking in the 2023 cognitive neuroscience category, it stands out among 115 peers, indicating its critical role in shaping contemporary research. The journal offers a comprehensive array of research articles, reviews, and methodologies aimed at researchers, professionals, and students alike, facilitating the exploration of complex cognitive functions. While not an open-access journal, it provides essential insights and significant contributions to the neuroscience community, making it an invaluable resource for anyone keen on delving into the intricacies of the human brain.

The Journal of Developmental Origins of Health and Disease is a premier academic publication under the esteemed Cambridge University Press, dedicated to advancing the understanding of how developmental processes influence health outcomes across the lifespan. With an ISSN of 2040-1744 and an E-ISSN of 2040-1752, this journal has established itself as a critical resource in the field of medicine, currently positioned in the Q2 category of Medicine (miscellaneous). Having converged from 2010 to 2024, this journal reflects a significant commitment to exploring the interconnections between early development and subsequent health conditions. Ranked 147 out of 398 in its category according to Scopus, it retains a commendable 63rd percentile status, highlighting its contributions to this rapidly evolving field. Though it does not offer open access, the journal remains a vital platform for researchers, professionals, and students interested in uncovering the intricate links between developmental biology and public health challenges.

Behavioral and Brain Functions is a leading Open Access journal published by BMC, dedicated to advancing the field of behavioral neuroscience, cognitive neuroscience, and biological psychiatry since its inception in 2005. This esteemed journal, based in the United Kingdom, has established itself as a vital resource for researchers and professionals, boasting a remarkable influence demonstrated by its Q1 and Q2 rankings across multiple relevant categories. With its commitment to providing unrestricted access to high-quality research, the journal facilitates the dissemination of significant findings in understanding the complex interactions between behavior and brain function. The journal ranks impressively within the Scopus database, positioning itself among the top-tier publications in its categories, making it an essential platform for academic discourse and innovation. As it converges through 2024, Behavioral and Brain Functions continues to play a crucial role in shaping the forefront of neuroscientific inquiry, inviting contributions that challenge our understanding and promote further exploration in these dynamic fields.

Frontiers in Toxicology, published by Frontiers Media SA, is a prominent open-access journal dedicated to advancing the understanding of toxicological science. Established in 2019, it serves as a vital forum for innovative research, offering insights into the pharmacological impacts and toxicological profiles of various substances. With its international reach based in Switzerland, this journal has quickly ascended in the academic community, achieving a notable Q1 ranking in Pharmacology, Toxicology and Pharmaceutics (Miscellaneous) and a Q2 ranking in Toxicology as of 2023. The journal is indexed in Scopus, where it ranks #8 out of 43 in its primary category, underscoring its influence and relevance in the field. The scope encompasses cutting-edge studies on the mechanisms of toxicity, including both human and environmental impacts, making it an essential resource for researchers, professionals, and students alike. By promoting open access to high-quality research, Frontiers in Toxicology plays a crucial role in enhancing knowledge sharing and fostering collaboration across disciplines.

Drug and Chemical Toxicology is a well-respected journal in the fields of toxicology, pharmacology, and public health, published by Taylor & Francis Ltd. Since its inception in 1978, this journal has diligently explored the effects and mechanisms of chemical exposures on health and the environment, fulfilling a crucial role in advancing scientific understanding and safeguarding public health. The journal is indexed across prestigious databases and features an impressive array of articles categorized within the Q2 and Q3 quartiles across various categories in 2023, reflecting its significance in Chemical Health and Safety as well as Environmental and Occupational Health disciplines. With an extensive reach and a focus on interdisciplinary research, Drug and Chemical Toxicology offers a rich repository of original research, reviews, and methodological advancements, catering to a diverse audience of researchers, professionals, and students dedicated to the betterment of safety and health standards. Although not an open-access publication, its articles are widely accessible to the academic community, ensuring that critical innovations and insights are shared for the greater good.